Bravias Capital Group’s Merck MRK Stock Holding History

Bravias Capital Group’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$346K	Buy	2,696 +113	+4%	+$13.2K	0.21%	66
2026 Q1	$311K	Sell	2,583 -1,581	-38%	-$183K	0.2%	69
2025 Q4	$438K	Sell	4,164 -474	-10%	-$44.5K	0.27%	64
2025 Q3	$389K	Buy	4,638 +1,383	+42%	+$114K	0.26%	70
2025 Q2	$258K	Buy	3,255 +109	+3%	+$8.66K	0.19%	85
2025 Q1	$282K	Sell	3,146 -111	-3%	-$10.4K	0.23%	66
2024 Q4	$322K	Buy	+3,257	New	+$336K	0.26%	64

Other funds holding MRK

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Bravias Capital Group's MRK Position: Q2 2026 in Review

Bravias Capital Group increased its Merck (MRK) stake by 4.4% in Q2 2026, buying an estimated $13.2K and bringing the position to 2,696 shares worth $346K. The position accounts for 0.21% of the portfolio, ranked #66.

Bravias Capital Group first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. The position peaked at $438K in Q4 2025. 1,752 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Bravias Capital Group held 2,696 shares of Merck worth $346K as of Q2 2026.
Bravias Capital Group bought 113 Merck shares in Q2 2026, an estimated $13.2K.
Merck made up 0.21% of Bravias Capital Group's portfolio in Q2 2026, its #66 holding.
Bravias Capital Group first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
Bravias Capital Group's Merck position peaked at $438K in Q4 2025.
1,752 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Bravias Capital Group's 13F filing for Q2 2026, filed 30 Jul 2026.